X0202 4 2008-05-08 1 0000725058 CYTOGEN CORP CYTO 0001135217 CARTER STEPHEN C/O CYTOGEN CORPORATION 650 COLLEGE ROAD EAST, STE 3100 PRINCETON NJ 08540 1 0 0 0 Common Stock 2008-05-08 4 D 0 2000 D 0 D Common Stock 2008-05-08 4 D 0 10000 D 0 D These shares were converted into the right to receive the merger consideration, as provided in the Agreement and Plan of Merger, dated March 10, 2008, by and among Cytogen Corporation, EUSA Pharma, Inc. and EUSA Pharma (USA), Inc. (the "Merger") of $0.62 per share. This restricted stock became fully vested and exercisable upon consummation of the Merger. In connection with the Merger, these shares were cancelled in exchange for the right to receive $0.62 per share. /s/ Stephen K. Carter 2008-05-09